Posted by Michael Wonder on 25 Oct 2023
At $550/month, new menopause hot flash drug may be out of reach for many women
24 October 2023 - Heralded as the first and only treatment thus far to block a source of hot flashes in menopausal women, recently approved Veozah’s monthly list price of $550 implies that insurance coverage and a patient assistance program will be critical to access. But both are limited in scope.
The FDA approved the once-daily oral tablet in May as a therapeutic to treat hot flashes and night sweats during menopause. Though Veozah (fezolinetant) is not the first drug licensed by the FDA to treat menopause, it is qualitatively distinct from what predates it.
